Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1584 of 5804
-
Could a common blood thinner help ventilated COVID-19 patients breathe easier?
Disease control CompletedThe Can nebulised HepArin Reduce morTality and time to Extubation in Patients with COVID-19 Requiring mechanical ventilation Meta-Trial (CHARTER-MT) is a prospective collaborative individual patient data analysis of randomised controlled trials and early phase studies. Individual…
Phase: PHASE2, PHASE3 • Sponsor: Australian National University • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New disc implant could replace neck fusion surgery
Disease control OngoingA multicenter, prospective, non-randomized, historically controlled study. Demonstrate the Synergy Disc is at least as safe and effective as conventional anterior cervical discectomy and fusion (ACDF) to treat cervical degenerative disc disease (DDD) in subjects who are symptomat…
Phase: NA • Sponsor: Synergy Spine Solutions • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Could a new pill curb heavy drinking? genetic clues may hold the answer
Disease control Recruiting nowFew medications are currently Food \& Drug Administration (FDA)-approved for the treatment of Alcohol Use Disorder (AUD), and those that are have, on average, modest effects on drinking. "Precision medicine" research has explored whether patient-level variables, such as genetic v…
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Tailor-Made vaccine aims to stop cancer return in High-Risk patients
Disease control CompletedThe primary objective of this study is to evaluate the safety, efficacy, and methodological feasibility of sequential administration of neoantigen-based personalized immunotherapy following completion of standard adjuvant therapy in patients with colorectal cancer or non-small ce…
Phase: PHASE1 • Sponsor: Ying Yuan, MD • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
ALS drug edaravone tested for Long-Term safety in pill form
Disease control CompletedThis is a Phase 3, international, multicenter, open-label, long-term extension study. The primary objective of this study is to evaluate the long-term safety and tolerability of oral edaravone in subjects with Amyotrophic Lateral Sclerosis (ALS) for up to 96 weeks.
Phase: PHASE3 • Sponsor: Shionogi • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New heart implant aims to ease heart failure burden
Disease control Recruiting nowThis study aims to monitor the safety and efficacy of Occlutech AFR device in patients with Heart Failure.
Sponsor: Occlutech International AB • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Heart patients get Double-Duty blood thinners in massive trial
Disease control CompletedThis study is a prospective, multicenter, parallel, open-label, randomized, controlled, superiority trial. It is planned to recruit 8,250 patients with multi-vessel disease(MVD), and the patients will be followed-up for at least 12 months after being implanted with a drug-eluting…
Phase: PHASE4 • Sponsor: Harbin Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New combo attack on tough liver cancer shows promise in Real-World study
Disease control CompletedThis is a multicenter,retrospective study to explore the effectiveness and safety of Atezo/Bev plus hepatic artery infusion chemotherapy (HAIC) among adult patients with high-risk HCC in real-world clinical practice in China. Eligible patients diagnosed with high-risk HCC initiat…
Phase: NA • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Jail-to-Freedom: which shot keeps opioid addiction in check?
Disease control OngoingThe proposed study is a Type 1 hybrid effectiveness-implementation trial. Individuals with opioid use disorder in county jails throughout the state of Maryland will be randomly assigned within gender within jail to one of two groups: Arm 1. XR-B (n=120). XR-B in jail followed by …
Phase: PHASE2, PHASE3 • Sponsor: Friends Research Institute, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New cocktail aims to knock out tough lymphoma
Disease control Recruiting nowThis phase I trial studies the side effects of polatuzumab vedotin when given with combination chemotherapy with or without glofitamab for the treatment of patients with untreated large B-cell lymphoma that grows and spreads quickly and has severe symptoms (aggressive). Polatuzum…
Phase: PHASE1 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New drug targets cancer spread in first human trial
Disease control Recruiting nowBackground: Metastasis is the spread of cancer from one organ to a nonadjacent organ. It causes 90% of cancer deaths. No treatment specifically prevents or reduces metastasis. Researchers hope a new drug can help. It stops cancer cells from growing and spreading further and poss…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New combo therapy targets Platinum-Resistant ovarian cancer
Disease control Recruiting nowThis is a Phase 1b open-label, multicenter study, evaluating the safety, tolerability, preliminary clinical activity, pharmacokinetics (PK), and pharmacodynamics of azenosertib (ZN-c3) in combination with other drugs.
Phase: PHASE1 • Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New pill shows promise in early brain tumor trial
Disease control Recruiting nowThe primary objective of this Phase 1, open-label, dose-escalation, and exploratory study is to evaluate the safety and tolerability profile (establish the maximum-tolerated dose) and evaluate the occurrence of dose-limiting toxicities (DLTs) following single weekly or multiple-d…
Phase: PHASE1 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New device aims to gently suck out brain clots without major surgery
Disease control Recruiting nowThis registry will study the use of the Aurora® Surgiscope to provide surgical access and visualization in minimally invasive removal of hematoma in the brain. Many methods of hematoma removal are available and will be based on surgeon preference. The impact of patient selection …
Sponsor: Integra LifeSciences Corporation • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Can a Parkinson's psychosis drug tame impulse control disorders?
Disease control CompletedThere is no consensus on the treatment of Impulse Control Disorder (ICD) in Parkinson Disease (PD) though it is recommended to reduce the dosage of dopamine agonists (DA). Reduction of DA frequently leads to a worsening of motor signs (parkinsonism or dyskinesias due to the conc…
Phase: PHASE2 • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New drug aims to tame inflammation in kidney patients
Disease control CompletedThe purpose of this research study is to compare the safety and effectiveness of 2 different doses of a study drug called ziltivekimab to placebo (an inactive substance) in reducing inflammation and improving some of the bad effects of inflammation on heart disease. Participants …
Phase: PHASE2 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Can a common supplement help alcoholic cirrhosis patients live longer?
Disease control Recruiting nowThe proposed of this randomized, double blinded, placebo-controlled study is to assess the effect of SAMe compared to placebo in patients with alcoholic cirrhosis Child Class A and B. The primary objective of the study is to test relationship between SAMe (S-adenosylmethionine) s…
Phase: PHASE2 • Sponsor: Indiana University • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Could a common blood thinner replace warfarin for tricky heart valve patients?
Disease control OngoingAtrial fibrillation (AF) is the most common sustained cardiac arrythmia encountered in clinical practice and patients suffer from this are at increased risk of ischemic stroke and systemic thromboembolism due to the formation and embolism of left atrial thrombi. Current internati…
Phase: PHASE4 • Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Lung stem cell infusion shows promise in early IPF trial
Disease control OngoingPurpose: To demonstrate the safety and efficacy of autologous Lung Spheroid Stem Cells (LSCs) administered by intravenous infusion in patients with idiopathic pulmonary fibrosis Progressive Fibrotic Interstitial Lung Disease. Participants: Patients with Idiopathic Pulmonary Fi…
Phase: PHASE1 • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Super-Sized flu shot aims to better shield seniors
Prevention CompletedPrimary Objective: To demonstrate that QIV-HD induced an immune response (as assessed by hemagglutination inhibition \[HAI\] geometric mean titers \[GMTs\] and seroconversion rates) that was superior to responses induced by QIV-SD for the 4 virus strains at 28 days post-vaccinat…
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Prevention
Last updated Jun 27, 2026 07:51 UTC